19 Aug 2013
Sponsorship opportunities now available.
> click here
19 Aug 2013
Abstract submissions open online 28 November 2013.
19 Aug 2013
Early bird registrations open online 14 January 2014.
The College of Intensive Care Medicine Annual Scientific Meeting (CICM ASM) has evolved from a continuing education seminar into a world-class scientific conference attracting renowned national and international speakers and intensive care specialists, senior trainees, and others who care for critically ill patients. Brisbane in 2014 will see the next step in this evolution, with, for the first time, concurrent clinical and non-clinical sessions, debates and “hypotheticals”, a paediatric track involving both clinical simulation and lectures, moderated research poster presentations, and sessions focussed specifically at senior trainees.
The theme of the 2014 Brisbane CICM ASM is “Intensive Care: It’s a Risky Business. Making decisions when there are no right answers”. Intensivists have a unique perspective on risk, managing many of the hospital’s patients whose treatments have not gone as planned, and monitoring patients at high risk of complications. Intensivists take daily responsibility for minimising risk using available resources. The ASM will identify decision points in clinical practice with no clear risk-free solution and outline how the risks of a complex ICU, including staff turnover and inexperience, legal risks, and the organisational risk of having two groups of clinicians feel they are in charge of a particular patient, can be mitigated. The goal will be to build consensus on how to practice in a risk-averse but overambitious healthcare system.
Our international speakers include Anders Perner from Copenhagen, who led the 6S trial of hydroxyethyl starch which found an association with renal failure, resulting in legal threats from the product manufacturer to recoup financial losses. Brian Cuthbertson from Sunnybrook in Toronto is currently studying the outcomes of critical illness syndromes, and is a lead investigator in the SuDDICU study (selective decontamination of the digestive tract) which will involve Australian and New Zealand sites. Brian was recently prominent in the media during a dispute with the family of a patient in a persistent vegetative state who sought legal authority to prevent the discontinuation of life support. Duncan Young from Oxford was the lead investigator in the PAC-MAN (pulmonary artery catheter), TRAC-MAN (early tracheostomy) and OSCAR (high-frequency oscillation ventilation) trials. He is the lead investigator in the ICON study examining long term outcomes after critical illness, and the DSMC chair of three major Australasian trials. Allan Goldman from Great Ormond Street Hospital in the UK focuses on the human factors aspect of team interfaces and mechanical support. Allan started the “Risky Business” (http://www.risky-business.com/) conferences in 2006.
Our national speakers, a mix of the “usual suspects” and younger intensivists, will address topics such as “Can ‘the system’ really reduce or mitigate the risk of an underperforming colleague”, “Paediatric syndromes graduating to adult ICUs”, “Superbugs”, “The risk of not adjusting drug doses in critical illness” and “The risks of having too many, and too few, ICU beds”.
Brisbane is an outstanding conference venue, with the Southbank entertainment precinct adjacent to the conference centre a great place to meet family and colleagues during and after the day’s activities. With Noosa, the Gold Coast and its theme parks an easy drive away, Brisbane in June is the perfect escape from colder climates.
We welcome you to Brisbane for the 2014 CICM ASM.
Professor Michael Reade
2014 ASM Scientific Convener